Effects of antiepileptic drugs on serum lipids profile among young adult Sudanese patient with epilepsy at Aljazeera State
DOI:
https://doi.org/10.30574/gscbps.2021.14.1.0027Keywords:
Anti-epileptic, Lipid profile, SudanAbstract
consequences that lead to an increase in risk of atherosclerosis in patients with epilepsy, several studies have reported that the patients commonly used antiepileptic drugs like phenytoin, and carbamazepine increase serum total Cholesterol, High Density Lipoproteins Cholesterol (HDL-C) Low Density lipoprotein Cholesterol ( LDL-C ) levels and Triglyceride (TG) .The aim of this study to assess and compare serum lipid profile of young adult patients treated by anti-epileptic drugs (phenytoin, oxcarbazepine and valproic acid) . Materials and Methods a cross-sectional study was conducted in Aljazeera state. Epileptic patients were of recruited. and taking antiepileptic drugs for more than six months and on regular follow up; approximately 120 patients on commonly used antiepileptic drugs (40 on phenytoin, 40 on oxcarbazepine, 40 on valproic Acid). Age and sex matching 40 controls were taken. our results show significant difference in the of mean TC, TG, HDL, and LDL-C levels in the group receiving phenytoin for more than six months when compared with control group P value (0.00) for all lipid profile. Also significant difference between the mean of TC, TG, HDL-C and LDL-C levels in the group receiving oxcarbazepine for more than six months when compared with control P value (0.00 ) for all lipid profile.
From the present study we concluded that CYP enzyme inducer anti-epileptic medicines like phenytoin and oxcarbazepine is strongly associated with increased levels of TC, LDL-C, HDL-C and TG, where asvalproate showed no significant change. Therefore, the serum cholesterol level should be regularly monitored in patients undergoing. Therapy with inducer anti-epileptic medicines.
Metrics
References
A Rahman, AJ Akhtar, SA Mateen. I NTERNATIONAL J OURNAL OF P HARMACY & L IFE S CIENCES Current therapeutic approaches to epilepsy. 2014; 4(1): 2282–2287.
AR Ziyaurrahman, J Patel. Anticonvulsant effect of Boswellia serrata by modulation of endogenous biomarkers. 2012; 4(4): 1308–1325.
O Article, K Manimekalai, B Visakan, KJ Salwe, S Murugesan. “Evaluation of Effct of Antiepileptic Drugs on Serum Lipid Profile among Young Adults with Epilepsy in a Tertiary Care Hospital in Pondicherry. 2014.
N. isorders. Seizures and the Epilepsies: Hope Through Research.
B Learning. Chapter 12 Neurologic Emergencies. 227–246.
NLC Talbot. The glossaries package v4 . 15 : a guide for beginners. 2015; 1–22.
Nikkila EA, Kaste M, Ehnbolm C, Viikari J. Increase in serum high-density lipoprotein in Phenytoin users. Br Med J. 1978; 2: 99-103.
MZ Rahman. Predicting Epileptic Seizure from Electroencephalography(EEG)using Hilbert Huang Transformation and Neural Network By Md . Naushad Karim. 2015.
N Coast, CF Campaign. s Continuing Co ontinu ing a Legacy y. 2016.
PN Banerjee, WA Hauser. Chapter 5, Incidence and Prevalence. 2007.
Bramswig S, Sudhop T, Luers C, et al. Lipoprotein(a) concen-tration increases during treatment with carbamazepine. Epilepsia. 2003; 44: 457-60.
D Nirmala. Studies on anticonvulsant activity of annacyclus pyrethrum in albino mice. 8(4): 2015.
K Phabphal, K Limapichat, P Sathirapanya, S Setthawatcharawanich, A Geater. Characterization of glucose homeostasis and lipid profile in adult , seizure-free , epileptic patients in Asian population. 2012; 1–7.
S Svalheim, G Luef, M Rauchenzauner, L Mørkrid, L Gjerstad. Cardiovascular risk factors in epilepsy patients taking levetiracetam , carbamazepine or lamotrigine. 2010; 122(13): 30–33.
X Pintó, A Muñoz, M Zúñiga, J Rubiés-prat, LF Pallardo, L Masana. Lipoprotein ratios : Physiological significance and clinical usefulness in cardiovascular prevention. 2009; 757–765.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.